Other Cancers Fixed-Dose Durvalumab Monotherapy in Previously Treated Urinary Tract Carcinoma Jun 01, 2023
Other Cancers Personalized Salvage Therapy for HL: Nivolumab Alone or in Combination With ICE Jun 01, 2023
Other Cancers Cabozantinib for Refractory Thyroid Cancer: Updated Results From COSMIC-311 Trial Jun 01, 2023
Other Cancers SANET-p Phase III Study of Surufatinib in Advanced Pancreatic Neuroendocrine Tumors Jun 01, 2023
Other Cancers Cytogenetic Abnormalities Impact Outcomes in Ixazomib vs Placebo for MM: Pooled Analysis Jun 01, 2023
Other Cancers Pelabresib and Ruxolitinib Combination vs Placebo and Ruxolitinib in JAK Inhibitor-Naïve MF Jun 01, 2023
